Siren, L.L.C. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0002005245

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2025 · 113 positions · Total reported value $3.35B · Top-10 concentration 46.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.7% · 15 new · 36 cut · 22 exited

Active Share (vs S&P 500): 97.6% · vs QQQ: 97.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -13.5% · vs SPY -15.6% · Prev Value $4.93B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.2% · vs SPY -6.4% · Latest Value $4.21B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, Siren, L.L.C. disclosed 113 equity positions with a combined reported value of $3.35B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 46.3% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were SRRK ($476.84M), KYMR ($255.75M), ONC ($151.91M). By sector, the heaviest allocations are Health Care 84.0%, Technology 4.9%. Versus the prior quarter, allocation shifted toward Health Care (+5.5pp) and away from Consumer Discretionary (-0.7pp), Technology (-0.9pp).

Versus the prior quarter, Siren, L.L.C. opened 15 new positions, trimmed 36 and fully exited 22, a turnover rate of 55.7% of positions. The portfolio's overlap with the prior quarter was 62% of names.

The largest new positions opened in Q4 2025 were OLMA ($82.52M), ZYME ($44.24M), DBVT ($35.61M).

Of the 22 positions fully exited versus the prior quarter, the largest were RNAM ($56.01M), RZLT ($45.78M), SLNO ($31.59M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • OLMA Olema Pharmaceuticals, Inc. · $82.52M
  • ZYME ZYMEWORKS INC · $44.24M
  • DBVT Dbv Technologies SA · $35.61M
  • ENGN enGene Therapeutics Inc. · $30.13M
  • MLYS MINERALYS THERAPEUTICS INC · $25.40M
  • FULC FULCRUM THERAPEUTICS INC COM · $22.05M
  • MNPR Monopar Therapeutics Inc. · $13.86M
  • IKT INHIBIKASE THERAPEUTICS INC · $11.99M

Fully Exited (vs previous quarter)

  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $56.01M
  • RZLT Rezolute, Inc. · prev qtr: $45.78M
  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $31.59M
  • NAMS NEWAMSTERDAM PHARMA CO NV · prev qtr: $21.78M
  • QURE UNIQURE NV · prev qtr: $16.06M
  • AVBP ARRIVENT BIOPHARMA INC · prev qtr: $12.91M
  • RNAC CARTESIAN THERAPEUTICS INC COM NEW · prev qtr: $5.76M
  • ELDN ELEDON PHARMACEUTICALS INC · prev qtr: $5.37M

Insider Transactions (Form 4)

Latest Siren, L.L.C. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Siren, L.L.C. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 116 positions worth $4.93B in total. HoldingsHub carries 8 quarters of its filings (Q3 2024–Q2 2026).

Portfolio Structure

  • 116 positions · $4.93B reported value (Q2 2026)
  • Top 10 holdings = 44.8% of reported value
  • Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 10.7%
  • Average position size: $42.48M

Sector Tilt

  • Health Care 92.0%
  • Information Technology 4.5%
  • Consumer Discretionary 1.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 32 added, 21 reduced, 9 exited
  • 38 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 84.0%
Technology 4.9%
Financials 0.1%
Other 8.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 10.83M $476.84M 14.22%
14.22%
Add
2 3.29M $255.75M 7.63%
7.63%
Reduce
3 500.00K $151.91M 4.53%
4.53%
Add
4 4.53M $112.41M 3.35%
3.35%
Add
5 1.34M $106.34M 3.17%
3.17%
Add
6 4.03M $100.73M 3.00%
3.00%
Add
7 1.50M $99.62M 2.97%
2.97%
Reduce
8 5.22M $87.80M 2.62%
2.62%
Hold
9 3.30M $82.52M 2.46%
2.46%
New
10 988.40K $78.49M 2.34%
2.34%
Add
11 1.08M $75.02M 2.24%
2.24%
Add
12 8.17M $72.35M 2.16%
2.16%
Add
13 3.01M $71.66M 2.14%
2.14%
Add
14 2.25M $71.33M 2.13%
2.13%
Hold
15 1.51M $70.18M 2.09%
2.09%
Reduce
16 3.50M $68.52M 2.04%
2.04%
Reduce
17 2.58M $64.77M 1.93%
1.93%
Hold
18 1.63M $57.87M 1.73%
1.73%
Reduce
19 2.00M $55.76M 1.66%
1.66%
Reduce
20 10.13M $55.71M 1.66%
1.66%
Reduce
21 499.98K $53.52M 1.60%
1.60%
Hold
22 235.86K $50.30M 1.50%
1.50%
Hold
23 1.38M $46.57M 1.39%
1.39%
Add
24 9.97M $45.96M 1.37%
1.37%
Hold
25 38.92M $44.76M 1.33%
1.33%
Hold
26 1.68M $44.24M 1.32%
1.32%
New
27 7.69M $43.37M 1.29%
1.29%
Add
28 2.45M $41.65M 1.24%
1.24%
Reduce
29 812.76K $36.43M 1.09%
1.09%
Hold
30 1.86M $35.61M 1.06%
1.06%
New
31 8.76M $32.58M 0.97%
0.97%
Hold
32 3.34M $30.13M 0.90%
0.90%
New
33 2.29M $28.63M 0.85%
0.85%
Reduce
34 818.60K $26.82M 0.80%
0.80%
Add
35 700.00K $25.40M 0.76%
0.76%
New
36 1.40M $23.06M 0.69%
0.69%
Add
37 1.62M $22.33M 0.67%
0.67%
Hold
38 1.95M $22.05M 0.66%
0.66%
New
39 708.47K $21.49M 0.64%
0.64%
Reduce
40 2.91M $17.70M 0.53%
0.53%
Hold
41 2.36M $17.59M 0.53%
0.53%
Hold
42 5.21M $16.15M 0.48%
0.48%
Hold
43 588.45K $15.98M 0.48%
0.48%
Reduce
44 2.01M $14.25M 0.42%
0.42%
Hold
45 212.30K $13.86M 0.41%
0.41%
New
46 1.19M $12.35M 0.37%
0.37%
Hold
47 300.00K $12.34M 0.37%
0.37%
Reduce
48 5.85M $11.99M 0.36%
0.36%
New
49 3.00M $11.94M 0.36%
0.36%
Add
50 51.50K $11.89M 0.35%
0.35%
Reduce

FAQ

What did Siren, L.L.C. buy in 2025-Q4?

In its 2025-Q4 13F filing, Siren, L.L.C. reported 113 equity positions worth $3.35B in aggregate; its largest disclosed positions were SRRK ($476.84M), KYMR ($255.75M), ONC ($151.91M).

How large is Siren, L.L.C.'s portfolio?

Siren, L.L.C. reported $3.35B of long equity holdings across 113 positions as of 2025-Q4. Top-10 holdings account for 46.3% of reported value.

What is Siren, L.L.C.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/siren/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →